Drug Type CAR-T |
Synonyms KLK2 CAR-T Cells |
Target |
Mechanism KLK2 inhibitors(Kallikrein 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic castration-resistant prostate cancer | Phase 1 | US | 28 Sep 2021 |